PB

Pathway Bioventures

North America, Illinois, United States, Chicago

Description

Pathway Bioventures is a seed-stage life sciences fund investing in next-generation therapeutics, medical device, and diagnostics companies.

Investor Profile

Pathway Bioventures has made 9 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (56%)
  • Series A (22%)
  • Debt Financing (11%)
  • Pre Seed (11%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Life Science
  • Therapeutics
  • Diabetes
  • 3d Printing
  • Artificial Intelligence (Ai)
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pathway Bioventures frequently co-invest with?

OM
North America, Massachusetts, United States, Boston
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
IA
North America, Indiana, United States, Bloomington
Co-Investments: 1
Generation Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
BioCrossroads
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Elevate Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Orange Grove Bio
North America, Ohio, United States, Cincinnati
Co-Investments: 1
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 1

Which angels does Pathway Bioventures often collaborate with?

PS
North America, California, United States, San Mateo
Shared Deals: 1

What are some of recent deals done by Pathway Bioventures?

Axonis Therapeutics

Boston, Massachusetts, United States

Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.

BiotechnologyLife ScienceMedical
Series AOct 30, 2024
Amount Raised: $115,000,000
Modifi Bio

New Haven, Connecticut, United States

Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics.

BiotechnologyMedicalTherapeutics
SeedOct 16, 2023
Amount Raised: $4,300,000
Afference

Boulder, Colorado, United States

Afference is an electronics manufacturing company that offers wearables that enable the digital dexterity of 3D digital content.

ElectronicsManufacturingWearables
Pre SeedSep 27, 2023
Amount Raised: $1,500,000
IpiNovyx Bio

West Nyack, New York, United States

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedOct 5, 2021
Amount Raised: $10,000,000
miRecule

Gaithersburg, Maryland, United States

MiRecule is an early-stage biotechnology company that focuses on developing Antibody RNA Conjugate (ARC) based therapeutics.

BiopharmaBiotechnologyHealth Care
SeedMay 28, 2021
Amount Raised: $5,700,000
CytoVale

San Francisco, California, United States

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

Artificial Intelligence (AI)Health DiagnosticsLife ScienceMachine Learning
Debt FinancingJan 4, 2021
Amount Raised: $16,435,000
Dimension Inx

Chicago, Illinois, United States

Dimension Inx specializes in developing regenerative microenvironments that give the body a blueprint to heal itself.

3D PrintingBiotechnologyMedicalTherapeutics
SeedNov 18, 2020
Amount Raised: $3,175,000
miRecule

Gaithersburg, Maryland, United States

MiRecule is an early-stage biotechnology company that focuses on developing Antibody RNA Conjugate (ARC) based therapeutics.

BiopharmaBiotechnologyHealth Care
SeedNov 5, 2019
Amount Raised: $1,500,000
Scioto Biosciences

Indianapolis, Indiana, United States

Scioto is a developer of Activated Bacterial Therapeutics platform.

BiotechnologyDiabetesHealth CareLife ScienceTherapeutics
Series AMay 21, 2018
Amount Raised: $1,800,000